Reply to the letter to the editor: Two-year results of treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy

被引：0
|
作者：
Masahiro Morimoto
Hidetaka Matsumoto
Kensuke Mimura
Hideo Akiyama
机构：
[1] Gunma University,Department of Ophthalmology
[2] School of Medicine,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2018年 / 256卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：225 / 226
页数：1
相关论文
共 50 条
  • [41] Two-year results of combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy
    Saito, Masaaki
    Iida, Tomohiro
    Kano, Mariko
    Itagaki, Kanako
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (09) : 2099 - 2110
  • [42] Outcomes of a 2-year treat-and-extend regimen with aflibercept for diabetic macular edema
    Takao Hirano
    Yuichi Toriyama
    Yoshihiro Takamura
    Masahiko Sugimoto
    Taiji Nagaoka
    Yoshimi Sugiura
    Fumiki Okamoto
    Michiyuki Saito
    Kousuke Noda
    Shigeo Yoshida
    Akihiro Ishibazawa
    Osamu Sawada
    Toshinori Murata
    Scientific Reports, 11
  • [43] Reply to the letter to the editor: genetic influence on visual outcomes of polypoidal choroidal vasculopathy
    Masayuki Hata
    Akitaka Tsujikawa
    Nagahisa Yoshimura
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2016, 254 : 1021 - 1022
  • [44] Reply to the letter to the editor: genetic influence on visual outcomes of polypoidal choroidal vasculopathy
    Hata, Masayuki
    Tsujikawa, Akitaka
    Yoshimura, Nagahisa
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (05) : 1021 - 1022
  • [45] Efficacy and Safety of Intravitreal Aflibercept Treat and Extend for Polypoidal Choroidal Vasculopathy in the ATLANTIC Study: A Randomized Clinical Trial
    Silva, Rufino
    Arias, Luis
    Nunes, Sandrina
    Farinha, Claudia
    Coimbra, Rita
    Marques, Joao P.
    Cachulo, Maria L.
    Figueira, Joao
    Barreto, Patricia
    Madeira, Maria H.
    Pires, Isabel
    Sousa, Joao C.
    Distefano, Laura
    Rosa, Paulo
    Carneiro, Angela
    Vaz-Pereira, Sara
    Meireles, Angelina
    Cabrera, Francisco
    Bures, Anniken
    Mendonca, Luis
    Fernandez-Vega-Sanz, Alvaro
    Barrao, Sandra
    Koh, Adrian
    Cheung, Chui Ming Gemmy
    Cunha-Vaz, Jose G.
    Murta, Joaquim
    OPHTHALMOLOGICA, 2022, 245 (01) : 80 - 90
  • [46] Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy
    Liu, Yang
    Guo, Jingli
    Tang, Wenyi
    Xu, Gezhi
    Liu, Wei
    BMC OPHTHALMOLOGY, 2024, 24 (01)
  • [47] Comparison of the 2-Year Results of Photodynamic Therapy with Aflibercept and Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy
    Miyakubo, Tomoko
    Mukai, Ryo
    Matsumoto, Hidetaka
    Morimoto, Masahiro
    Takahashi, Maki
    Nagai, Kazuki
    Nakamura, Kosuke
    Hoshino, Junki
    Akiyama, Hideo
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 571 - 577
  • [48] One-year results of modified Treat-and-Extend regimen using aflibercept for diabetic macular edema; VIBIM study
    Sagong, Min
    Shin, Jae Pil
    Kim, Yu Cheol
    Kim, Hyun Woong
    Lee, Sang-Joon
    Chung, In Young
    Park, Sung Who
    Pak, Kang Yeun
    Donggeun, Park
    Lee, Ji Eun E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [49] Two-year outcome of aflibercept for treatment-naive patient with neovascular age-related macular degeneration using modified treat-and-extend regimen
    Ohnaka, Masayuki
    Nagai, Yoshimi
    Kimura, Motoki
    Chihara, Tomoyuki
    Nakagawa, Kazuki
    Fujita, Kyoko
    Takahashi, Kanji
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [50] Two-Year Outcomes of Treat-and-Extend Intravitreal Aflibercept for Exudative Age-Related Macular Degeneration A Prospective Study
    Maruko, Ichiro
    Ogasawara, Masashi
    Yamamoto, Akiko
    Itagaki, Kanako
    Hasegawa, Taiji
    Arakawa, Hisaya
    Nakayama, Makiko
    Koizumi, Hideki
    Okada, Annabelle A.
    Sekiryu, Tetsuju
    Iida, Tomohiro
    OPHTHALMOLOGY RETINA, 2020, 4 (08): : 767 - 776
12345